Jefferies Financial Group Reiterates “€77.00” Price Target for Bayer (BAYN)

Share on StockTwits

Bayer (FRA:BAYN) has been assigned a €77.00 ($89.53) price target by research analysts at Jefferies Financial Group in a research note issued on Thursday. The brokerage presently has a “neutral” rating on the healthcare company’s stock. Jefferies Financial Group’s price target would suggest a potential upside of 1.18% from the company’s current price.

A number of other brokerages have also recently weighed in on BAYN. Goldman Sachs Group set a €111.00 ($129.07) target price on shares of Bayer and gave the stock a “buy” rating in a report on Tuesday, September 25th. Independent Research set a €105.00 ($122.09) target price on shares of Bayer and gave the stock a “neutral” rating in a report on Monday, July 16th. Kepler Capital Markets set a €84.00 ($97.67) target price on shares of Bayer and gave the stock a “buy” rating in a report on Monday, September 24th. Citigroup set a €93.00 ($108.14) target price on shares of Bayer and gave the stock a “neutral” rating in a report on Tuesday, August 28th. Finally, HSBC set a €82.00 ($95.35) target price on shares of Bayer and gave the stock a “neutral” rating in a report on Thursday, September 13th. Seven analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Bayer has a consensus rating of “Buy” and an average target price of €98.80 ($114.88).

Shares of FRA:BAYN opened at €76.10 ($88.49) on Thursday. Bayer has a 1-year low of €91.58 ($106.49) and a 1-year high of €123.82 ($143.98).

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Featured Article: Closed-End Mutual Funds (CEFs)

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply